Analysts Set Phreesia, Inc. (NYSE:PHR) Target Price at $31.00

Shares of Phreesia, Inc. (NYSE:PHR) have received a consensus rating of “Buy” from the twelve ratings firms that are presently covering the stock, Marketbeat Ratings reports. Twelve investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $31.00.

Several analysts have recently commented on the company. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. JMP Securities restated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Citigroup upped their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Finally, Robert W. Baird dropped their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th.

Insider Buying and Selling

In other news, SVP Amy Beth Vanduyn sold 25,447 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total value of $532,605.71. Following the completion of the sale, the senior vice president now owns 93,470 shares of the company’s stock, valued at approximately $1,956,327.10. This represents a 21.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michael Weintraub sold 15,152 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $21.01, for a total transaction of $318,343.52. Following the completion of the sale, the director now owns 242,827 shares of the company’s stock, valued at approximately $5,101,795.27. This represents a 5.87 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 100,034 shares of company stock worth $2,378,581. 5.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Phreesia

Institutional investors have recently made changes to their positions in the company. International Assets Investment Management LLC grew its stake in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia during the 2nd quarter worth $202,000. Point72 DIFC Ltd acquired a new stake in shares of Phreesia during the 2nd quarter worth $209,000. XTX Topco Ltd acquired a new stake in shares of Phreesia during the 3rd quarter worth approximately $247,000. Finally, Hsbc Holdings PLC bought a new position in Phreesia in the second quarter valued at about $301,000. Institutional investors own 92.10% of the company’s stock.

Phreesia Stock Performance

Shares of NYSE PHR opened at $27.24 on Thursday. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94. Phreesia has a one year low of $17.07 and a one year high of $29.16. The business has a fifty day simple moving average of $23.54 and a 200 day simple moving average of $22.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the prior year, the business posted ($0.58) earnings per share. The business’s revenue was up 16.6% compared to the same quarter last year. Sell-side analysts expect that Phreesia will post -1.1 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.